Mina T. Kelleni
Mina T. Kelleni
Minia University, College of Medicine, Pharmacology Department
Verified email at
Cited by
Cited by
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
MT Kelleni
Pharmacological research 157, 104874, 2020
Nonalcoholic fatty liver disease: current and potential therapies
MA Ibrahim, M Kelleni, A Geddawy
Life sciences 92 (2), 114-118, 2013
Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
MT Kelleni
Biomedicine & Pharmacotherapy 133, 110982, 2021
Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in rats: impact of oxidative stress, inflammation, and apoptosis
MT Kelleni, EF Amin, AM Abdelrahman
Journal of toxicology 2015, 2015
Tocilizumab, remdesivir, favipiravir, and dexamethasone repurposed for COVID-19: a comprehensive clinical and pharmacovigilant reassessment
MT Kelleni
SN Comprehensive Clinical Medicine 3 (4), 919-923, 2021
Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis
MA Ibrahim, IA Albahlol, FA Wani, AAE Tammam, MT Kelleni, MU Sayeed, ...
Chemico-Biological Interactions 338, 109402, 2021
Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammation and apoptosis
MT Kelleni, SA Ibrahim, AM Abdelrahman
Toxicology mechanisms and methods 26 (5), 371-377, 2016
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects
MT Kelleni
Expert Review of Anti-infective Therapy 20 (1), 17-21, 2022
Drug induced cardiotoxicity: mechanism, prevention and management
MT Kelleni, M Abdelbasset
Cardiotoxicity, 2018
Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease
M Ibrahim, E Farghaly, W Gomaa, M Kelleni, AM Abdelrahman
European journal of pharmacology 659 (2-3), 289-295, 2011
ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror
MT Kelleni
Inflammopharmacology 28 (6), 1477-1480, 2020
Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy
MT Kelleni
Biomedicine & Pharmacotherapy 139, 111626, 2021
NSAIDs/Nitazoxanide/Azithromycin Immunomodulatory Protocol Used in Adult, Geriatric, Pediatric, Pregnant, and Immunocompromised COVID-19 Patients: A Real-World Experience
MT Kelleni
Canadian Journal of Medicine 3, 121-143, 2021
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators
MT Kelleni
Immunologic Research, 2021
SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality
MT Kelleni
Journal of Infection 82 (2), e35, 2021
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
MT Kelleni
Inflammopharmacology 30 (1), 343-348, 2022
Evolution of SARS CoV-2 omicron subvariants BF. 7 and XBB. 1.5: time to follow Africa and abort all COVID restrictions
MT Kelleni
Journal of Infection 86 (4), 405, 2023
SARS CoV-2 vaccination autoimmunity, antibody dependent Covid-19 enhancement and other potential risks: beneath the tip of the iceberg
MT Kelleni
Int J Pulm Respir Sci 5 (2), 1-10, 2021
Real-life practice of the Egyptian Kelleni's protocol in the current tripledemic: COVID-19, RSV and influenza
MT Kelleni
Journal of Infection 86 (2), 154-225, 2023
Chamomile tea potentials in prevention and amelioration of type 2 diabetes mellitus
MT Kelleni
J Diabetes Metab 7 (1), 2016
The system can't perform the operation now. Try again later.
Articles 1–20